Netflix just set a new 52-week low at $65.04, 3.01% under the October 2 bottom it reached less than three weeks ago. The $270.8 billion streaming leader is making new lows within weeks of its last one.
Netflix just set a new 52-week low at $65.04, 3.01% under the October 2 bottom it reached less than three weeks ago. The $270.8 billion streaming leader is making new lows within weeks of its last one.
Marriott just cleared $404, a 52-week high that tops the June 12 peak of $399.81 by 0.57% and ends four months of stalling under that ceiling. The $105 billion hotel operator is now in open air with no overhead resistance from the past year.
Fiverr just marked a fresh 52-week low at $8.39, 0.94% under the prior floor set on October 6 and roughly a third of where it traded a year ago. Market cap is down to $301 million, so $8.39 is the line bulls need to hold.
Fastenal just cleared its August 11 peak with a $52.49 close, a fresh 52-week high for the $60 billion distributor. The stock has climbed roughly 35% off last November's $38.91 low, and there's no overhead resistance left on the one-year chart.
Agilent just set a fresh 52-week high at $177.75, 1.25% above the peak it made less than a week ago. The life sciences tools maker has now added more than 60% from its March low near $110.88.
Copper closed up 3.68%, a one-day gain the red metal rarely posts. Anyone holding miners or copper-linked ETFs just got a fresh mark to measure from.
NOBL has been the go-to choice for dividend-growth investors, but a closer look at the numbers against a rival ETF reveals a performance gap so wide it forces a hard question about whether loyalty to a strategy is costing you real money.
Leveraged ETFs charge a management fee you can see on the fact sheet, but a second party quietly collects a separate financing fee. A familiar name from the crypto world just bought its way into that hidden revenue stream.
XRP has shed nearly half its value over the past year, yet some investors still believe 5,000 coins could grow into a life-changing sum by 2030. The path there depends on a set of conditions that are getting harder to meet by the month.
EBITDA margin widened to 13.3% from 11.7% a year ago, enough to clear consensus earnings by 15% even with revenue missing expectations. Management raised full-year revenue and adjusted EPS guidance on the strength of it.
The beat is real but thin: GAAP operating income fell 56% to $718 million as R&D spending on autonomy, Optimus and AI compute climbed. Battery supply capped deliveries, leaving the largest passenger vehicle backlog in four years. Margins are now the price of the robotics bet.
United American's health unit swung to a $6.4 million underwriting loss on severity claims at Evry and a CMS processing delay, pushing both lines below consensus and trimming full-year operating income guidance. Management calls the hit isolated, pointing to higher 2027 guidance and a raised buyback target.